Citation Impact

Citing Papers

Actualización en síndrome hemolítico urémico atípico: diagnóstico y tratamiento. Documento de consenso
2015
Tubular kidney injury molecule‐1 (KIM‐1) in human renal disease
2007 Standout
How to Screen for Non-Adherence to Antihypertensive Therapy
2016
Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial
2004
Chronic Hypoxia and Tubulointerstitial Injury
2005
Resistant hypertension and obstructive sleep apnea in the setting of kidney disease
2012
Long-term renal consequences of hypertension for normal and diseased kidneys
2002
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
The Triad of Sleep Apnea, Hypertension, and Chronic Kidney Disease: A Spectrum of Common Pathology
2016 Standout
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Timed Urine Collections Are Not Needed to Measure Urine Protein Excretion in Clinical Practice
2005
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
Mechanisms of hypoxia signalling: new implications for nephrology
2019 StandoutNobel
Timed Urine Collections Are Not Needed to Measure Urine Protein Excretion in Clinical Practice
2005
ACE Inhibitors to Prevent End-Stage Renal Disease
2001
Prevalence of Kidney Damage in Australian Adults
2003
Management of Glomerular Proteinuria
2003
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
2001 Standout
Combined Effects of Low-dose Oral Spironolactone and Captopril Therapy in a Rat Model of Spontaneous Hypertension and Heart Failure
2003
Baseline Predictors of Renal Disease Progression in the African American Study of Hypertension and Kidney Disease
2006
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
2001 Standout
The Effect of Lowering LDL Cholesterol on Vascular Access Patency
2014
Proteinuria: Its clinical importance and role in progressive renal disease
2000
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
2010 Standout
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
2016 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Efficacy and Safety of Benazepril for Advanced Chronic Renal Insufficiency
2006
An introduction to biomarkers: applications to chronic kidney disease
2007
Early Experience with Dual Kidney Transplantation in Adults using Expanded Donor Criteria
1999
Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
2013 Standout
Chronic Kidney Disease at High Altitude
2008
The Effect of Pre-existing Ischaemic Heart Disease on Renal Dysfunction in Cardiac Transplant Recipients
2002
A Molecular Signature of Proteinuria in Glomerulonephritis
2010
Cellular oxygen sensing in health and disease
2007 StandoutNobel
Chronic kidney disease
2011 Standout
Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
2010 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
2012 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Dialysis Arteriovenous Fistula Failure and Angioplasty: Intimal Hyperplasia and Other Causes of Access Failure
2016
Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares
2007
Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM)
2014
Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury
2000
Role of Remission Clinics in the Longitudinal Treatment of CKD
2008
Kidney-Heart Interactions
2005
Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on blood pressure and the kidney
2003
Cardiorenal Syndrome
2008 Standout
Pathophysiology of proteinuria
2003
Acute kidney injury
2021 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
2011 Standout
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts
2011
Antihypertensive and antiproteinuric efficacy of ramiprilin children with chronic renal failure
2004
Insulin and insulin resistance:
2004 Standout
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade
2002
Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study
2007
Early Change in Proteinuria as a Surrogate End Point for Kidney Disease Progression: An Individual Patient Meta-analysis
2014
Patency Rates of the Arteriovenous Fistula for Hemodialysis: A Systematic Review and Meta-analysis
2013
Idiopathic focal segmental glomerulosclerosis
2003
Effects of Enalapril versus Placebo as a Treatment for Canine Idiopathic Glomerulonephritis
2000
Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study
2000
Obstructive sleep apnea syndrome and chronic kidney disease: a new cardiorenal risk factor
2014
Survival in Recipients of Marginal Cadaveric Donor Kidneys Compared with Other Recipients and Wait-Listed Transplant Candidates
2001 Standout
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy
2006
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Association of Single Measurements of Dipstick Proteinuria, Estimated Glomerular Filtration Rate, and Hematocrit with 25-Year Incidence of End-Stage Renal Disease in the Multiple Risk Factor Intervention Trial
2006
Expression of nephrin in acquired human glomerular disease
2002
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Chronic Kidney Disease
2016 Standout
Guidelines for the Identification, Evaluation, and Management of Systemic Hypertension in Dogs and Cats
2007 Standout
Mesangial Matrix Modulation and Glomerulosclerosis
1999
Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases
2004
Retinoids Regulate the Repairing Process of the Podocytes in Puromycin Aminonucleoside-induced Nephrotic Rats
2003 StandoutNobel
A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome
2000
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
2011 Standout
ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats
2018 Standout
Guidelines for the Identification, Evaluation, and Management of Systemic Hypertension in Dogs and Cats
2007 Standout
Effects of Enalapril versus Placebo as a Treatment for Canine Idiopathic Glomerulonephritis
2000
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Cell Biology of the Glomerular Podocyte
2003 Standout
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis
2010
TGF‐β signaling and the fibrotic response
2004 Standout
Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes
2006
How should proteinuria be detected and measured?
2009
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate‐to‐severe reductions in renal function
2005
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2004 Standout
Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
2013 Standout
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure
2006 Standout
Mechanisms of Tubulointerstitial Injury in the Kidney: Final Common Pathways to End-stage Renal Failure
2004
Prevalence of chronic renal disease in Spain: results of the EPIRCE study.
2010
Kidney Hypoxia, Attributable to Increased Oxygen Consumption, Induces Nephropathy Independently of Hyperglycemia and Oxidative Stress
2013
Evaluation and Management of Proteinuria and Nephrotic Syndrome in Children: Recommendations From a Pediatric Nephrology Panel Established at the National Kidney Foundation Conference on Proteinuria, Albuminuria, Risk, Assessment, Detection, and Elimination (PARADE)
2000
Proteinuria, Chronic Kidney Disease, and the Effect of an Angiotensin Receptor Blocker in Addition to an Angiotensin-Converting Enzyme Inhibitor in Patients With Moderate to Severe Heart Failure
2009
Progression, remission, regression of chronic renal diseases
2001
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
2020 Standout
Thrombotic Microangiopathy with Targeted Cancer Agents
2011
Dapagliflozin in Patients with Chronic Kidney Disease
2020 Standout
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Management of idiopathic membranous nephropathy
2010
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout

Works of Roberto Pisoni being referenced

Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies
1997
How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
1998
The Epidemiology of Severe Acute Kidney Injury: from BEST to PICARD, in Acute Kidney Injury: New Concepts
2008
Characterization and treatment of resistant hypertension
2009
Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies
1998
Effect of high dose ramipril with or without indomethacin on glomerular selectivity
2002
Statin Therapy Is Not Associated with Improved Vascular Access Outcomes
2010
Drug-Induced Thrombotic Microangiopathy
2001
Refractory Hypertension: Definition, Prevalence, and Patient Characteristics
2011
Pretreatment blood pressure reliably predicts progression of chronic nephropathies
2000
How much must blood pressure be reduced in order to obtain the remission of chronic renal disease?
2000
Refractory Hypertension
2015
Renoprotective Therapy in Patients With Nondiabetic Nephropathies
2001
Diverse Effects of Increasing Lisinopril Doses on Lipid Abnormalities in Chronic Nephropathies
2003
Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
2003
Rankless by CCL
2026